What is Generate Biomedicines, Inc. 's shares (diluted)?

Generate Biomedicines, Inc. (GENB) reported shares (diluted) of 64.9M in Q1 2026.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Generate Biomedicines, Inc. GENB Shares (Diluted)

Shares (Diluted) at other companies

MYR GroupMYRG

15.7M-2.4%

RepligenRGEN

56.7M+0.2%

Silgan HoldingsSLGN

105.9M-1.4%

SezzleSEZL

34.9M-3.4%

Hancock Whitney CorporationHWC

82.3M-4.9%

SeaboardSEB

957.8K-1.4%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's shares (diluted)?: Generate Biomedicines, Inc. (GENB) reported shares (diluted) of 64.9M in Q1 2026.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.